Avior Wealth Management LLC Has $2.21 Million Stake in Corteva, Inc. $CTVA

Avior Wealth Management LLC lifted its position in shares of Corteva, Inc. (NYSE:CTVA) by 464.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 32,901 shares of the company’s stock after buying an additional 27,075 shares during the quarter. Avior Wealth Management LLC’s holdings in Corteva were worth $2,205,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Brighton Jones LLC boosted its holdings in shares of Corteva by 307.2% in the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock valued at $888,000 after purchasing an additional 11,760 shares in the last quarter. Woodline Partners LP lifted its holdings in Corteva by 40.3% in the first quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after buying an additional 16,644 shares during the period. Cetera Investment Advisers lifted its holdings in Corteva by 2.9% in the second quarter. Cetera Investment Advisers now owns 132,333 shares of the company’s stock valued at $9,863,000 after buying an additional 3,748 shares during the period. Avantax Advisory Services Inc. grew its stake in Corteva by 23.3% during the second quarter. Avantax Advisory Services Inc. now owns 25,674 shares of the company’s stock worth $1,913,000 after purchasing an additional 4,853 shares during the period. Finally, Rockefeller Capital Management L.P. grew its stake in Corteva by 34.0% during the second quarter. Rockefeller Capital Management L.P. now owns 62,648 shares of the company’s stock worth $4,669,000 after purchasing an additional 15,891 shares during the period. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Performance

CTVA opened at $77.34 on Friday. Corteva, Inc. has a 12-month low of $53.40 and a 12-month high of $80.90. The company’s 50 day moving average is $75.10 and its 200 day moving average is $69.40. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The company has a market cap of $52.01 billion, a price-to-earnings ratio of 48.95, a PEG ratio of 2.67 and a beta of 0.72.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting the consensus estimate of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The business had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. During the same quarter in the previous year, the firm earned $0.32 earnings per share. The company’s revenue for the quarter was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities research analysts predict that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, March 16th. Investors of record on Monday, March 2nd were issued a $0.18 dividend. The ex-dividend date of this dividend was Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is 45.57%.

Analysts Set New Price Targets

CTVA has been the topic of several research reports. Wells Fargo & Company increased their price objective on shares of Corteva from $77.00 to $85.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. BNP Paribas Exane boosted their price objective on Corteva from $72.00 to $74.00 in a report on Monday, March 9th. Wall Street Zen lowered shares of Corteva from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Royal Bank Of Canada boosted their price objective on Corteva from $80.00 to $89.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on shares of Corteva from $85.00 to $90.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $82.90.

Insider Activity

In related news, insider Brian Titus sold 8,311 shares of the stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the sale, the insider owned 8,090 shares in the company, valued at approximately $619,289.50. This represents a 50.67% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.14% of the company’s stock.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.